Stock Market 27 May 2026

Lichen International Stock Trades Higher Ahead of Nasdaq Open

Lichen International Stock Trades Higher Ahead of Nasdaq Open

Lichen International Limited shares were up in early U.S. trading after a choppy Tuesday session. The small Nasdaq-listed China financial-services stock continued a strong move, though there was little new company news out to explain the demand. The stock traded at $1.52, up 14 cents, or about 10% over the last close, according to market data. Shares opened Tuesday at $1.32 and swung from $1.26 to $1.71, Yahoo Finance data showed. Volume was around 543,580 shares.
June 3, 2026
XTL Biopharmaceuticals Stock in Focus Following Nasdaq Delisting Deadline

XTL Biopharmaceuticals Stock in Focus Following Nasdaq Delisting Deadline

XTL Biopharmaceuticals Ltd. shares ticked up Wednesday, with traders focused on the Nasdaq hearing process that may determine if the Israeli biotech will retain its U.S. listing. The stock traded at $2.44, rising 2.5% from its last close at $2.38. Nasdaq Composite barely changed, up 0.07%. S&P 500 edged up 0.02%. The company’s listing dispute was the driver, not the broad market.
May 27, 2026
Xcel Brands Stock Under Pressure as Small Share Sale Puts Cash in Spotlight

Xcel Brands Stock Under Pressure as Small Share Sale Puts Cash in Spotlight

Xcel Brands shares were little changed Wednesday. A new filing showed just a small amount drawn from its $15 million equity purchase line, so investors remain focused on cash, potential dilution, and progress with Xcel’s influencer turnaround plan. Shares of the Nasdaq-traded microcap traded at $2.08 to $2.10 in the afternoon, moving between $2.03 and $2.11 for the day with light volume. The stock lost 5.4% Tuesday and was down 6.2% last Friday, giving up a short-lived earnings bounce earlier last week.
May 27, 2026
Twin Disc Stock Is Up Again: The $179.5 Million Number Traders Are Watching

Twin Disc Stock Is Up Again: The $179.5 Million Number Traders Are Watching

Twin Disc, Incorporated shares rose on Wednesday, extending a post-holiday rebound, as investors kept the small industrial company’s latest backlog and margin gains in view. The stock was recently at $17.36, up 1.8%, with a market value of about $250 million and volume near 31,400 shares. U.S. trading was taking place inside normal Nasdaq market hours, 9:30 a.m. to 4 p.m. Eastern time, after Monday’s Memorial Day closure. Nasdaq’s 2026 calendar lists the next full U.S. equity-market holiday as Juneteenth on June 19.
May 27, 2026
MediaCo Shares Up, Nasdaq Decision Ahead for MDIA

MediaCo Shares Up, Nasdaq Decision Ahead for MDIA

MediaCo Holding Inc. ticked up Wednesday, but the stock stuck under $1. Shares last changed hands at $0.8987, gaining around 1%, with an intraday range from $0.8626 to $0.8996. Around 18,601 shares traded. Market cap stood at roughly $73.4 million. But even with the recent gain, the listing issue remains. In December, MediaCo said Nasdaq flagged its shares for a minimum bid-price violation after they traded below $1 for 30 days in a row. The clock runs until June 17, 2026—MediaCo has to get shares to close at $1 or higher for 10 straight business days to get back into compliance. Otherwise, delisting could follow. The company said it might look at moves like a reverse stock split.
May 27, 2026
Traders Eye $850 Million ThomasLloyd Deal as Roman DBDR Stock Stays Quiet

Traders Eye $850 Million ThomasLloyd Deal as Roman DBDR Stock Stays Quiet

Roman DBDR Acquisition Corp. II stuck close to $10.52 Wednesday, as investors paid more attention to the SPAC’s coming merger with ThomasLloyd Climate Solutions than to its limited activity now. The Nasdaq stock edged up less than 0.1% in a narrow range between $10.50 and $10.52. Volume was about 115,000 shares. Roman DBDR is sitting just below its $10.56 per-share redemption value from March 31. That redemption value is what a SPAC investor can pull from the trust account instead of staying in after the deal vote.
May 27, 2026
Why Omeros Stock Is Sliding Today Even as Biotech Shares Climb

Why Omeros Stock Is Sliding Today Even as Biotech Shares Climb

Omeros Corp shares dropped on Wednesday, falling 3.9% to $11.20 by late morning in New York, as investors marked down the Seattle biotech even while sector funds gained. The stock opened at $11.77, touched $12.02 and then slid as low as $11.17, with about 1.38 million shares changing hands. That divergence mattered. The SPDR S&P Biotech ETF, an exchange-traded fund — a basket of shares that trades like one stock — rose 1.3%, while the iShares Nasdaq Biotechnology ETF gained 0.9%. For a small-cap drug developer, falling on a firmer biotech tape tends to put the focus back on company-specific execution.
May 27, 2026
Accuray Stock Nearly Hit 50 Cents — Then the Rally Faded

Accuray Stock Nearly Hit 50 Cents — Then the Rally Faded

Accuray Inc. shares gave back an early push on Wednesday, slipping 0.9% to $0.3712 after touching $0.4982 in intraday trade, a sharp swing in a stock with a market value of about $44.6 million. More than 14.4 million shares had changed hands by late morning in New York. The whipsaw matters because there was no fresh corporate release to trade on. Accuray’s investor site still showed its May 15 research pact with the University of Wisconsin-Madison and its May 6 quarterly results as the latest press releases, with no upcoming events listed; Nasdaq was in normal trading hours on Wednesday after its May 25 Memorial Day closure.
May 27, 2026
Julong falls after Nasdaq trading pause for JLHL

Julong falls after Nasdaq trading pause for JLHL

Julong Holding Limited shares were down in late-morning Wednesday. The China-based intelligent-systems contractor has been volatile since Nasdaq halted the stock late Tuesday. Class A shares ended last at $17.44, off 9.1% from the prior close. The stock opened at $18.10 and dropped to a session low of $16.11. About 19,344 shares changed hands, with light volume leaving prices sensitive to small trades.
May 27, 2026
BioNexus Gene Lab Stock Edges Up While Nasdaq Microcap Faces Chemrex Cash Battle

BioNexus Gene Lab Stock Edges Up While Nasdaq Microcap Faces Chemrex Cash Battle

BioNexus Gene Lab Corp. traded up 1.45% to $2.10 in light action Wednesday, with less than 3,000 shares moving on Nasdaq. Market cap was around $5.1 million. The last posted trade came at 10:10 a.m. EDT, pointing to the stock’s lack of liquidity. Trading picked up during the regular U.S. session after the Memorial Day holiday shut markets Monday. Nasdaq’s standard hours are 9:30 a.m. to 4 p.m. Eastern, and the exchange’s 2026 calendar lists May 25—not May 27—as a market holiday.
May 27, 2026
First Interstate BancSystem Stock Is Back in Focus After Shelf Filing and Analyst Cut

First Interstate BancSystem Stock Is Back in Focus After Shelf Filing and Analyst Cut

First Interstate BancSystem Inc. filed a new automatic shelf registration on Tuesday, giving the Montana-based regional bank room to raise capital later, a move that put FIBK back in focus after the shares closed higher and a market headline reported a D.A. Davidson downgrade. A shelf registration is a standing SEC filing that lets a company sell securities later, usually with a new supplement spelling out the price, size and underwriters. First Interstate’s May 26 filing covered common stock, preferred stock, depositary shares, debt securities, warrants, purchase contracts and units.
May 27, 2026
Karat Packaging Stock Slips Before $0.45 Dividend Payout As Tariff Costs Stay In Focus

Karat Packaging Stock Slips Before $0.45 Dividend Payout As Tariff Costs Stay In Focus

Karat Packaging Inc shares were little changed to weaker ahead of Wednesday’s regular trading session, with investors looking past a broad rebound in U.S. equities and toward the foodservice packaging company’s dividend payment and tariff-driven margin outlook. Karat stock was quoted at $26.46, down 7 cents, or about 0.3%, from the prior close, with the latest trade recorded late Tuesday after hours. The Nasdaq-listed company had a market value of about $531 million.
May 27, 2026
This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade

This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade

enVVeno Medical Corp. shares were last available at $11.25 before regular Nasdaq trading on Wednesday, up 18 cents from the prior close, giving the Irvine, California-based medical-device developer a market value of about $7.4 million. It is a small stock, so a modest price move can carry more noise than signal. The timing matters. Nasdaq’s regular market runs from 9:30 a.m. to 4 p.m. Eastern, and U.S. equity markets had just come through Monday’s Memorial Day closure; Wednesday was set up as a normal trading day, not a holiday tape.
May 27, 2026
Vestand Stock Gains Premarket as Nasdaq Eyes Delisting Over 50-Cent Price

Vestand Stock Gains Premarket as Nasdaq Eyes Delisting Over 50-Cent Price

Vestand Inc. shares traded up premarket Wednesday. The small-cap said Nasdaq has started a review that may delist its securities after a string of late filings. The stock traded around $0.50 in premarket, after closing at $0.47 on Tuesday with a 16.5% gain. Premarket activity is typically thin and can see sharper moves. Nasdaq's main session is 9:30 a.m. to 4:00 p.m. Eastern, with premarket from 4:00 a.m. to 9:30 a.m.
May 27, 2026
First United Moves Premarket as FUNC Jumps

First United Moves Premarket as FUNC Jumps

First United Corporation shares traded up ahead of Wednesday's U.S. open, putting the Maryland bank in a stronger spot after a drawn-out holiday week. The Nasdaq-listed shares traded at $38.17, up 93 cents, or 2.5% from the prior close, per market data. Regular trading on Nasdaq hadn’t started yet at the dateline; pre-market hours for Nasdaq run 4:00 a.m. to 9:30 a.m. Eastern, then regular hours go from 9:30 a.m. to 4:00 p.m.
May 27, 2026
FG Merger II Stock Trades Near Its High After Boxabl Gets Texas Nod, Eyes on June Vote

FG Merger II Stock Trades Near Its High After Boxabl Gets Texas Nod, Eyes on June Vote

FG Merger II Corp. shares hovered just under their 52-week peak after Boxabl, the modular-home startup it's taking public, got the go-ahead to sell and install its Casita Studio in Texas. FGMC ended Tuesday's session at $10.33, up 0.15%. It moved between $10.32 and $10.34 on the day, according to Google Finance. Timing is key here. FGMC is going into a June 9 shareholder vote on merging with Boxabl, which is less than two weeks away. Meanwhile, Boxabl just landed new state-level approval, giving it another operational win to show investors ahead of that vote.
May 27, 2026
Casey’s Shares Move Lower Ahead of Results, With Margin Uncertainty in Focus

Casey’s Shares Move Lower Ahead of Results, With Margin Uncertainty in Focus

Casey’s General Stores shares edged down in recent trading, despite a price target bump from Wells Fargo. The move puts a fresh focus on the company’s fuel margins ahead of its earnings report in June. The stock was at $809.41, dropping $15.90 from the previous close, and puts the company’s value around $30.1 billion. Nasdaq’s regular session hadn’t started yet in New York; hours are 9:30 a.m. to 4 p.m. ET, with pre-market starting at 4 a.m. ET.
May 27, 2026
Voyager Therapeutics Stock Is Waking Up Before a Make-or-Break Tau Window

Voyager Therapeutics Stock Is Waking Up Before a Make-or-Break Tau Window

Voyager Therapeutics edged higher in late trading ahead of Wednesday’s regular Nasdaq session, with investors again focused on whether the company’s Alzheimer’s pipeline can move from lab data into human studies this year. Nasdaq’s regular session opens at 9:30 a.m. Eastern time, so the early price action was still thin pre-market/overnight trading, where prices can move on limited volume. That matters now because Voyager is approaching the part of the biotech calendar that can reset expectations. The company has said its investigational new drug, or IND, process for VY1706 is on track in the second quarter; an IND is the request that allows a company to begin U.S. human testing.
May 27, 2026
UK & AU Stock Market Today: Live Updates 27.05.2026

UK & AU Stock Market Today: Live Updates 27.05.2026

LIVEMarkets rolling coverageStarted: May 27, 2026, 4:00 AM EDTUpdated: May 28, 2026, 3:56 AM EDT AnteoTech's Ultranode 95 Boosts Drone Battery Performance Amid US Validation May 28, 2026, 3:56 AM EDT. AnteoTech (ASX:ADO) CEO Merrill Gray highlights recent US validation of the Ultranode 95 silicon anode battery technology, enhancing next-generation drone batteries. The company also focuses on battery safety through its Anteo S solution and plans expansion into key global markets. Investors should watch for upcoming commercial milestones through 2026 as AnteoTech pushes forward in the growing drone sector. Long Shortz with AnteoTech: Battery tech validation accelerates drone market push
May 27, 2026
Zenas BioPharma Stock Slips as a June Catalyst Moves Into View

Zenas BioPharma Stock Slips as a June Catalyst Moves Into View

Zenas BioPharma shares ended lower on Tuesday, lagging a firmer biotech tape as investors looked past the long U.S. market weekend and toward a June presentation for its lead autoimmune drug. The Nasdaq-listed stock was quoted at $18.73, down about 1.3%, after trading between $18.61 and $19.27. Its 52-week range runs from $8.91 to $44.60, underscoring how much trial news still drives the name.
May 27, 2026
Bluemount Holds Steady Above IPO as Volume Picks Up—BMHL in Focus

Bluemount Holds Steady Above IPO as Volume Picks Up—BMHL in Focus

Bluemount Holdings Limited shares traded on Nasdaq pushed above the $4 IPO price on Tuesday, picking up as volume jumped during a wider U.S. market advance. The Hong Kong-based financial services and timepiece trading company finished at $4.38, gaining 2 cents, or 0.46%. Shares opened at $4.30 and moved between $4.18 and $4.40, according to market data. Trading volume jumped to around 18,000 shares, well over the 1,000 shares seen in the previous session on May 22.
May 27, 2026
1 6 7 8 9 10 127